美股市场个股详情
ENOV Enovis Corp
- 44.520
- +0.570+1.30%
交易中 12/26 15:57 (美东)
24.88亿总市值-20.52市盈率TTM
44.610最高价43.520最低价28.23万股成交量43.850今开43.950昨收1248.99万成交额0.53%换手率亏损市盈率(静)5587.55万总股本65.03052周最高0.75市净率23.80亿流通值38.27052周最低--股息TTM5345.91万流通股106.918历史最高--股息率TTM2.48%振幅7.561历史最低44.244平均价1股每手
关于Enovis Corp公司
Enovis Corp 是一家医疗技术公司，专注于通过制造和分销广泛用于重建手术、康复、疼痛管理和物理治疗的高质量医疗设备，开发临床差异化解决方案，从而产生可衡量的患者结果并改变工作流程。 该公司通过两个运营部门开展业务：预防与恢复部门 (P&R) 和重建部门(Recon)。 它的大部分收入来自预防和恢复部门。
公司介绍
公司代码ENOV
公司名称Enovis Corp
上市日期2008/05/08
成立日期1995
CEOMr. Matthew L. Trerotola
所属市场纽交所
员工数量6550
年结日12-31
公司地址2711 Centerville Road,Suite 400
城市Wilmington
省份特拉华州
国家美国
邮编19808
电话1-302-252-9160
董事高管
- 姓名
- 职务
- 年薪
- Matthew L. Trerotola
- Chairman of the Board and Chief Executive Officer
- 1077.46万
- Phillip Benjamin Berry
- Senior Vice President and Chief Financial Officer
- 235.77万
- Brady R. Shirley
- President, Chief Operating Officer and Director
- 520.38万
- John Kleckner
- Vice President, Controller and Chief Accounting Officer
- --
- Patricia A. Lang
- Senior Vice President and Chief Human Resources Officer
- 207.28万
- Daniel A. Pryor
- Executive Vice President, Strategy and Business Development
- 475.30万
- Bradley J. Tandy
- Senior Vice President and General Counsel
- --
- Terry D. Ross
- Group President, Prevention and Recovery
- --
- Louie Vogt
- Group President, Reconstructive
- --
- Rajiv Vinnakota
- Independent Director
- 29.89万
- Philip A. Okala
- Independent Director
- 28.39万
- Angela S. Lalor
- Independent Director
- 29.65万
- Liam J. Kelly
- Independent Director
- 28.39万
- A. Clayton Perfall
- Independent Director
- 30.89万
- Dr. Christine Ortiz, B.S.,M.S.,PhD
- Independent Director
- 28.39万
- Barbara W. Bodem
- Independent Director
- 28.39万
- Sharon L. Wienbar
- Lead Independent Director
- 31.65万
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据